Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beat von Albertini

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Contributions to Nephrology|August 9, 2007
Double high-flux hemodiafiltrationBeat von Albertini
Contributions to Nephrology|December 23, 2011
Producing on-line ultrapure dialysis fluidBeat von Albertini
Hemodialysis International. International Symposium on Home Hemodialysis|January 31, 2006
Clinical use of high-efficiency hemodialysis treatments: long-term assessmentJuan P Bosch, Susie Q Lew, Viroj Barlee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2007
Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/betaH Andreas Bock, Patricia Hirt-Minkowski, Michel Brünisholz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2004
Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort studyJean-Pierre Wauters, Jean-Luc Bosson, Giacomo Forneris, et al.
Journal of Nephrology|May 21, 2004
The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patientsGilles Pernod, Jean-Luc Bosson, Dela Golshayan, et al.
Nephron. Clinical Practice|April 15, 2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcetMartin Wilkie, Giuseppe Pontoriero, Fernando Macário, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidismPiergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Contributions to Nephrology|August 9, 2007
Double high-flux hemodiafiltrationBeat von Albertini
Contributions to Nephrology|December 23, 2011
Producing on-line ultrapure dialysis fluidBeat von Albertini
Hemodialysis International. International Symposium on Home Hemodialysis|January 31, 2006
Clinical use of high-efficiency hemodialysis treatments: long-term assessmentJuan P Bosch, Susie Q Lew, Viroj Barlee, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 25, 2007
Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/betaH Andreas Bock, Patricia Hirt-Minkowski, Michel Brünisholz, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 15, 2004
Patient referral is influenced by dialysis centre structure in the Diamant Alpin Dialysis cohort studyJean-Pierre Wauters, Jean-Luc Bosson, Giacomo Forneris, et al.
Journal of Nephrology|May 21, 2004
The Diamant Alpin Dialysis cohort study: clinico-biological characteristics and cardiovascular genetic risk profile of incident patientsGilles Pernod, Jean-Luc Bosson, Dela Golshayan, et al.
Nephron. Clinical Practice|April 15, 2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcetMartin Wilkie, Giuseppe Pontoriero, Fernando Macário, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidismPiergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Pageof 1